维昇药业-B(02561.HK):委任陆楹为首席财务官
Core Viewpoint - Vison Pharmaceutical-B (02561.HK) announced the appointment of Lu Ying as the Chief Financial Officer, effective from October 13, 2025 [1] Company Summary - Lu Ying has been appointed as the Chief Financial Officer of Vison Pharmaceutical-B [1]